Merit Medical Systems (NASDAQ:MMSI) Releases FY 2025 Earnings Guidance

Key Points

• Merit Medical Systems has updated its FY 2025 earnings guidance, projecting an EPS of 3.520-3.720 and revenue of $1.5 billion.
• The company's stock has a market capitalization of $5.01 billion and a current price-to-earnings ratio of 43.04.
• Recent analyst ratings show a consensus of "Moderate Buy" with a price target averaging $107.00.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) issued an update on its FY 2025 earnings guidance on Saturday morning. The company provided earnings per share (EPS) guidance of 3.520-3.720 for the period, compared to the consensus estimate of 3.343. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Needham & Company LLC restated a "buy" rating and set a $108.00 price target on shares of Merit Medical Systems in a research note on Friday, July 18th. Piper Sandler lowered their target price on Merit Medical Systems from $110.00 to $105.00 and set an "overweight" rating for the company in a research note on Thursday, July 31st. Canaccord Genuity Group set a $112.00 target price on Merit Medical Systems and gave the company a "buy" rating in a research note on Wednesday, May 21st. Raymond James Financial lowered their target price on Merit Medical Systems from $108.00 to $102.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Finally, Robert W. Baird reduced their price target on Merit Medical Systems from $111.00 to $110.00 and set an "outperform" rating for the company in a report on Friday, April 25th. Two analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Merit Medical Systems has a consensus rating of "Moderate Buy" and an average price target of $107.00.

Merit Medical Systems Stock Performance

NASDAQ:MMSI traded down $0.94 during trading hours on Wednesday, reaching $83.55. 531,905 shares of the stock were exchanged, compared to its average volume of 667,655. The company has a quick ratio of 2.66, a current ratio of 4.09 and a debt-to-equity ratio of 0.49. The firm has a 50 day simple moving average of $90.95 and a 200-day simple moving average of $96.91. Merit Medical Systems has a 52 week low of $81.04 and a 52 week high of $111.45. The stock has a market capitalization of $4.95 billion, a P/E ratio of 42.41, a P/E/G ratio of 2.79 and a beta of 0.66.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The medical instruments supplier reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.16. The business had revenue of $382.46 million for the quarter, compared to the consensus estimate of $372.47 million. Merit Medical Systems had a return on equity of 15.07% and a net margin of 8.31%. The business's revenue was up 13.2% on a year-over-year basis. During the same quarter last year, the business posted $0.92 EPS. As a group, sell-side analysts forecast that Merit Medical Systems will post 3.37 earnings per share for the current fiscal year.

Insider Transactions at Merit Medical Systems

In related news, CFO Raul Jr. Parra sold 15,181 shares of the firm's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $93.75, for a total value of $1,423,218.75. Following the sale, the chief financial officer directly owned 24,201 shares in the company, valued at $2,268,843.75. This trade represents a 38.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director F. Ann Millner sold 21,250 shares of Merit Medical Systems stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $96.47, for a total value of $2,049,987.50. Following the transaction, the director owned 34,543 shares in the company, valued at approximately $3,332,363.21. This trade represents a 38.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 85,596 shares of company stock worth $8,171,433 over the last quarter. Insiders own 3.20% of the company's stock.

Institutional Trading of Merit Medical Systems

An institutional investor recently raised its position in Merit Medical Systems stock. AQR Capital Management LLC raised its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 7.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,361 shares of the medical instruments supplier's stock after buying an additional 1,114 shares during the period. AQR Capital Management LLC's holdings in Merit Medical Systems were worth $1,730,000 at the end of the most recent quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.